Prevalence of TMC278 (rilpivirine) associated mutations in the Frankfurt Resistance Database
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Virology
Reference16 articles.
1. Is it safe to switch between efavirenz and nevirapine in the event of toxicity?;Mehta;Lancet Infect Dis,2007
2. Safety and tolerability of etravirine;Portilla;Enferm Infecc Microbiol Clin,2009
3. Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy;Antinori;AIDS,2001
4. DUET-1 study group. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial;Madruga;Lancet,2007
5. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial;Lazzarin;Lancet,2007
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antiviral Medication in Sexually Transmitted Diseases. Part II: HIV;Mini-Reviews in Medicinal Chemistry;2015-03-05
2. Rilpivirine resistance and the dangerous liaisons with substitutions at position 184 among patients infected with HIV-1: Analysis from a national drug-resistance database (ARCA);Journal of Medical Virology;2014-05-17
3. Prevalence in the USA of rilpivirine resistance-associated mutations in clinical samples and effects on phenotypic susceptibility to rilpivirine and etravirine;Antiviral Therapy;2014
4. Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland;Journal of the International AIDS Society;2014-01
5. Rilpivirine: drug profile of a second-generation non-nucleoside reverse transcriptase HIV-inhibitor;Expert Review of Anti-infective Therapy;2013-11-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3